Carlisle Regional Cancer Center — Carlisle, Pennsylvania

Carlisle Regional Cancer Center is a clinical research site located in Carlisle, Pennsylvania, United States 17015.

Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.

Carlisle Regional Cancer Center has participated in 51 clinical trials with 47 currently active.

Therapeutic areas: Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Carlisle

Browse all research sites in Pennsylvania · View every site in Carlisle

Sponsor Feasibility Report

Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carlisle Regional Cancer Center?

Carlisle Regional Cancer Center has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carlisle Regional Cancer Center conducted?

Carlisle Regional Cancer Center has 51 clinical trials on record, with 47 currently active. Their work covers Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.

Is Carlisle Regional Cancer Center accredited by Crixeo Clinical Trials?

Carlisle Regional Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carlisle Regional Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.